Clinical trial
Intra-nasal vs. Intra-venous Ketamine Administration as an add-on to Antidepressant Therapy
NCT02644629 is registered in ClinicalTrials.gov with Shalvata Mental Health Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intra-nasal vs. Intra-venous Ketamine Administration as an add-on to Antidepressant Therapy
- Lead sponsor
- Shalvata Mental Health Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- May 31, 2020
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.